Table 1 Characteristics of the patients included in the study (n = 115)
From: Prescription trends at the end of life in a palliative care unit: observational study
Characteristics | N = 115 |
|---|---|
Age (years), mean ± SD | 70.0 ± 12.9 |
Length of hospitalization (days), Mdn (Q1;Q3) | 10 (5; 33) |
Gender, n (%) | |
Male | 62 (53.9) |
Female | 53 (46.1) |
Provenance, n (%) | |
HPCST | 104 (90.4) |
CCICT | 11 (9.6) |
Primary diagnosis, n (%) | |
Cancer | 97 (84.3) |
Heart failure | 5 (4.3) |
COPD | 3 (2.6) |
Ulcers | 3 (2.6) |
Renal failure | 2 (1.7) |
Other | 5 (4.5) |
Location primary cancer, n (%) | |
Lung | 20 (20.6) |
Stomach | 11 (11.3) |
Colorectal | 11 (11.3) |
Central nervous system | 9 (9.3) |
Head and Neck | 6 (6.1) |
Esofagus | 6 (6.1) |
Pancreas | 6 (6.1) |
Liver | 4 (4.1) |
Uterus | 4 (4.1) |
Other | 20 (20.6) |
Extension of disease, n (%) | |
Metastatic | 55 (56.7) |
Locally advanced /unknown | 42 (43.3) |
Co-morbid conditions, n (%) | |
1 | 20 (17.4) |
2 to 4 | 64 (55.7) |
> 4 | 21 (18.2) |
None/ unknown | 10 (8.7) |
PPS, n (%) | |
≤ 20 | 29 (27.1) |
30 | 29 (25.2) |
40 | 37 (32.2) |
50 | 11 (9.6) |
60 | 1 (0.9) |